EDGAR Filing Documents for 0001193125-23-071012

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

SEC Accession No. 0001193125-23-071012

Filing Date

2023-03-15

Accepted

2023-03-15 12:53:27

Documents

Group Members

NAN FUNG GROUP HOLDINGS LTDNAN FUNG LIFE SCIENCES HOLDINGS LTDNF INVESTMENT HOLDINGS LTDNFLS BETA LTDNFLS PLATFORM HOLDINGS LTDPIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD.PIVOTAL LIFE SCIENCES HOLDINGS LTDPIV

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G	d440994dsc13g.htm	SC 13G	161243
2	EX-99.1	d440994dex991.htm	EX-99.1	13358
	Complete submission text file	0001193125-23-071012.txt		176583

Mailing Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107

Business Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107 (345) 949 1040

Pivotal bioVenture Partners Fund I, L.P. (Filed by) CIK: 0001695076 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13G

Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300

Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423

Oculis Holding AG (Subject) CIK: 0001953530 (see all company filings)